OLLA, STEFANIA
OLLA, STEFANIA
Istituto di Ricerca Genetica e Biomedica - IRGB
A large-scale screening identified in USH2A gene the P3272L founder pathogenic variant explaining familial Usher syndrome in Sardinia, Italy
2024 Serra, Rita; Rallo, Vincenzo; Steri, Maristella; Olla, Stefania; Piras, Maria Grazia; Marongiu, Michele; Gorospe, Myriam; Schlessinger, David; Pinna, Antonio; Fiorillo, Edoardo; Cucca, Francesco; Angius, Andrea
Biological Potential of Asphodelus microcarpus Extracts: α-Glucosidase and Antibiofilm Activities In Vitro
2024 Floris, Sonia; Pintus, Francesca; Fais, Antonella; Era, Benedetta; Raho, Nicola; Siguri, Chiara; Orrù, Germano; Fais, Sara; Tuberoso, Carlo Ignazio Giovanni; Olla, Stefania; Di Petrillo, Amalia
Exploring Asphodelus microcarpus as a source of xanthine oxidase inhibitors: Insights from in silico and in vitro studies
2024 Di Petrillo, A; Siguri, C; Delogu, Gl; Fais, A; Era, B; Floris, S; Pintus, F; Kumar, A; Fantini, Mc; Olla, S
OTULIN-related conditions: Report of a new case and review of the literature using GenIA
2024 Caballero-Oteyza, A.; Crisponi, L.; Peng, X. P.; Wang, H.; Mrovecova, P.; Olla, S.; Siguri, C.; Marnissi, F.; Jouhadi, Z.; Aksentijevich, I.; Grimbacher, B.; Proietti, M.
The Antioxidant Drug Edaravone Binds to the Aryl Hydrocarbon Receptor (AHR) and Promotes the Downstream Signaling Pathway Activation
2024 Veroni, Caterina; Olla, Stefania; Brignone, Maria Stefania; Siguri, Chiara; Formato, Alessia; Marra, Manuela; Manzoli, Rosa; Macario, Maria Carla; Ambrosini, Elena; Moro, Enrico; Agresti, Cristina
Inhibitory Effect of Quercetin on Oxidative Endogen Enzymes: A Focus on Putative Binding Modes
2023 Olla, Stefania; Siguri, Chiara; Fais, Antonella; Era, Benedetta; Claudio Fantini, Massimo; Di Petrillo, Amalia
Synthesis and Characterization of Edaravone Analogues as Remyelinating Agents and Putative Mechanistic Probes
2023 Colombo, Eleonora; Olla, Stefania; Minnelli, Cristina; Formato, Alessia; Veroni, Caterina; Corbisiero, Silvia; Pericolo, Mattia; Siguri, Chiara; Mobbili, Giovanna; Agresti, Cristina; Seneci, Pierfausto
An USH2A founder mutation is the cause of Usher syndrome type 2 in Sardinia
2022 Rallo, Vincenzo; Serra, Rita; Steri, Maristella; Olla, Stefania; Marongiu, Michele; Fiorillo, Edoardo; Pinna, Antonio; Cucca, Francesco; Angius, Andrea
COMPOUNDS FOR USE IN PROGRESSIVE MULTIPLE SCLEROSIS
2022 Martino, G.; Panina, P.; Nait-Oumesmar, B.; Baron Van Evercooren, A.; Kuhlmann, T.; Baranzini, S.; Goebels, N.; Zipp, F.; Hanuscheck, N.; Antel, J.; Agresti, C.; Olla, S.; Parravicini, C.; Eberini, I.; Abbracchio, Mp.; Bresciani, A.
Combining human genetics of multiple sclerosis with oxidative stress phenotype for drug repositioning
2021 Olla, Stefania; Steri, ANNA MARISTELLA; Formato, Alessia; Whalen Michael, B; Corbisiero, Silvia; Agresti, Cristina
A Sardinian founder mutation in glycoprotein Ib platelet subunit beta(GP1BB) that impacts thrombocytopenia
2020 Busonero, Fabio; Steri, Maristella; Orru, Valeria; Sole, Gabriella; Olla, Stefania; Marongiu, Michele; Maschio, Andrea; Sidore, Carlo; Lai, Sandra; Mulas, Antonella; Zoledziewska, Magdalena; Floris, Matteo; Pala, Mauro; Forabosco, Paola; Asunis, Isadora; Pitzalis, Maristella; Deidda, Francesca; Masala, Marco; Caria, Cristian Antonio; Barella, Susanna; Abecasis, Goncalo R.; Schlessinger, David; Sanna, Serena; Fiorillo, Edoardo; Cucca, Francesco
Complex genetic signatures in immune cells underlie autoimmunity and inform therapy
2020 Orrù, V; Steri, M; Sidore, C; Marongiu, M; Serra, V; Olla, S; Sole, G; Lai, S; Dei, M; Mulas, A; Virdis, F; Piras, Mg; Lobina, M; Marongiu, M; Pitzalis, M; Deidda, F; Loizedda, A; Onano, S; Zoledziewska, M; Sawcer, S; Devoto, M; Gorospe, M; Abecasis, Gr; Floris, M; Pala, M; Schlessinger, D; Fiorillo, E; Cucca, F
Identification and validation of edaravone remyelinating targets in oligodendrocyte progenitor cells
2020 Alessia Formato; Giada Mele; Pierfausto Seneci; Eleonora Colombo; Giovanna Mobbili; Cristina Minnelli; Caterina Veroni; Stefania Olla;Cristina Agresti
Oxidative Status in Multiple Sclerosis and Off-Targets of Antioxidants: The Case of Edaravone
2020 Agresti, Cristina; Mechelli, Rosella; Olla, Stefania; Veroni, Caterina; Eleuteri, Cecilia; Ristori, Giovanni; Salvetti, Marco
Confirmation of a new phenotype in an individual with a variant in the last part of exon 30 of CREBBP
2019 Angius, Andrea; Uva, Paolo; Oppo, Manuela; Persico, Ivana; Onano, Stefano; Olla, Stefania; Pes, Valentina; Perria, Chiara; Cuccuru, Gianmauro; Atzeni, Rossano; Serra, Gigliola; Cucca, Francesco; Sotgiu, Stefano; Hennekam Raoul, C; Crisponi, Laura
Dissection of the BAFF pathway in Multiple Sclerosis with a view toward more specific and effective therapies
2019 Olla, S; Idda, Ml; Deiana, M; Delogu, G; Lodde, V; Steri, M; Orrù, V; Floris, M; Pitzalis, M Pala M; Sidore, C; Mulas, A; Piras, Mg; Lobina, M; Lai, S; Marongiu, Mara; Serra, V; Marongiu, Michele; Sole, G; Busonero, F; Maschio, A; Dei, M; Deidda, F; Poddie, F; Farina, G; Frau, J; Costa, G; Coghe, G; Lorefice, L; Fenu, G; Marrosu, Mg; Cocco, E; Fiorillo, E; Zoledziewska, M; Cucca, F
Rational design and synthesis of edaravone- remyelinating analogues and probes: a preliminary SAR
2019 Seneci, Pierfausto; Colombo, Eleonora; Pericolo, Mattia; Veroni, Caterina; Formato, Alessia; Mele, Giada; Camerini, Serena; Crescenzi, Marco; Stefania Brignone, Maria; Mallozzi, Cinzia; Olla, Stefania; Agresti, Cristina
Genetic-Driven Druggable Target Identification and Validation
2018 Floris, Matteo; Olla, Stefania; Schlessinger, David; Cucca, Francesco
Molecular Similarity in Computational Toxicology
2018 Floris, Matteo; Olla, Stefania
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials
2017 Eleuteri C.; Olla S.; Veroni C.; Umeton R.; Mechelli R.; Romano S.; Buscarinu M.C.; Ferrari F.; Calo G.; Ristori G.; Salvetti M.; Agresti C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A large-scale screening identified in USH2A gene the P3272L founder pathogenic variant explaining familial Usher syndrome in Sardinia, Italy | 1-gen-2024 | Serra, Rita; Rallo, Vincenzo; Steri, Maristella; Olla, Stefania; Piras, Maria Grazia; Marongiu, Michele; Gorospe, Myriam; Schlessinger, David; Pinna, Antonio; Fiorillo, Edoardo; Cucca, Francesco; Angius, Andrea | |
| Biological Potential of Asphodelus microcarpus Extracts: α-Glucosidase and Antibiofilm Activities In Vitro | 1-gen-2024 | Floris, Sonia; Pintus, Francesca; Fais, Antonella; Era, Benedetta; Raho, Nicola; Siguri, Chiara; Orrù, Germano; Fais, Sara; Tuberoso, Carlo Ignazio Giovanni; Olla, Stefania; Di Petrillo, Amalia | |
| Exploring Asphodelus microcarpus as a source of xanthine oxidase inhibitors: Insights from in silico and in vitro studies | 1-gen-2024 | Di Petrillo, A; Siguri, C; Delogu, Gl; Fais, A; Era, B; Floris, S; Pintus, F; Kumar, A; Fantini, Mc; Olla, S | |
| OTULIN-related conditions: Report of a new case and review of the literature using GenIA | 1-gen-2024 | Caballero-Oteyza, A.; Crisponi, L.; Peng, X. P.; Wang, H.; Mrovecova, P.; Olla, S.; Siguri, C.; Marnissi, F.; Jouhadi, Z.; Aksentijevich, I.; Grimbacher, B.; Proietti, M. | |
| The Antioxidant Drug Edaravone Binds to the Aryl Hydrocarbon Receptor (AHR) and Promotes the Downstream Signaling Pathway Activation | 1-gen-2024 | Veroni, Caterina; Olla, Stefania; Brignone, Maria Stefania; Siguri, Chiara; Formato, Alessia; Marra, Manuela; Manzoli, Rosa; Macario, Maria Carla; Ambrosini, Elena; Moro, Enrico; Agresti, Cristina | |
| Inhibitory Effect of Quercetin on Oxidative Endogen Enzymes: A Focus on Putative Binding Modes | 1-gen-2023 | Olla, Stefania; Siguri, Chiara; Fais, Antonella; Era, Benedetta; Claudio Fantini, Massimo; Di Petrillo, Amalia | |
| Synthesis and Characterization of Edaravone Analogues as Remyelinating Agents and Putative Mechanistic Probes | 1-gen-2023 | Colombo, Eleonora; Olla, Stefania; Minnelli, Cristina; Formato, Alessia; Veroni, Caterina; Corbisiero, Silvia; Pericolo, Mattia; Siguri, Chiara; Mobbili, Giovanna; Agresti, Cristina; Seneci, Pierfausto | |
| An USH2A founder mutation is the cause of Usher syndrome type 2 in Sardinia | 1-gen-2022 | Rallo, Vincenzo; Serra, Rita; Steri, Maristella; Olla, Stefania; Marongiu, Michele; Fiorillo, Edoardo; Pinna, Antonio; Cucca, Francesco; Angius, Andrea | |
| COMPOUNDS FOR USE IN PROGRESSIVE MULTIPLE SCLEROSIS | 1-gen-2022 | Martino, G.; Panina, P.; Nait-Oumesmar, B.; Baron Van Evercooren, A.; Kuhlmann, T.; Baranzini, S.; Goebels, N.; Zipp, F.; Hanuscheck, N.; Antel, J.; Agresti, C.; Olla, S.; Parravicini, C.; Eberini, I.; Abbracchio, Mp.; Bresciani, A. | |
| Combining human genetics of multiple sclerosis with oxidative stress phenotype for drug repositioning | 1-gen-2021 | Olla, Stefania; Steri, ANNA MARISTELLA; Formato, Alessia; Whalen Michael, B; Corbisiero, Silvia; Agresti, Cristina | |
| A Sardinian founder mutation in glycoprotein Ib platelet subunit beta(GP1BB) that impacts thrombocytopenia | 1-gen-2020 | Busonero, Fabio; Steri, Maristella; Orru, Valeria; Sole, Gabriella; Olla, Stefania; Marongiu, Michele; Maschio, Andrea; Sidore, Carlo; Lai, Sandra; Mulas, Antonella; Zoledziewska, Magdalena; Floris, Matteo; Pala, Mauro; Forabosco, Paola; Asunis, Isadora; Pitzalis, Maristella; Deidda, Francesca; Masala, Marco; Caria, Cristian Antonio; Barella, Susanna; Abecasis, Goncalo R.; Schlessinger, David; Sanna, Serena; Fiorillo, Edoardo; Cucca, Francesco | |
| Complex genetic signatures in immune cells underlie autoimmunity and inform therapy | 1-gen-2020 | Orrù, V; Steri, M; Sidore, C; Marongiu, M; Serra, V; Olla, S; Sole, G; Lai, S; Dei, M; Mulas, A; Virdis, F; Piras, Mg; Lobina, M; Marongiu, M; Pitzalis, M; Deidda, F; Loizedda, A; Onano, S; Zoledziewska, M; Sawcer, S; Devoto, M; Gorospe, M; Abecasis, Gr; Floris, M; Pala, M; Schlessinger, D; Fiorillo, E; Cucca, F | |
| Identification and validation of edaravone remyelinating targets in oligodendrocyte progenitor cells | 1-gen-2020 | Alessia Formato; Giada Mele; Pierfausto Seneci; Eleonora Colombo; Giovanna Mobbili; Cristina Minnelli; Caterina Veroni; Stefania Olla;Cristina Agresti | |
| Oxidative Status in Multiple Sclerosis and Off-Targets of Antioxidants: The Case of Edaravone | 1-gen-2020 | Agresti, Cristina; Mechelli, Rosella; Olla, Stefania; Veroni, Caterina; Eleuteri, Cecilia; Ristori, Giovanni; Salvetti, Marco | |
| Confirmation of a new phenotype in an individual with a variant in the last part of exon 30 of CREBBP | 1-gen-2019 | Angius, Andrea; Uva, Paolo; Oppo, Manuela; Persico, Ivana; Onano, Stefano; Olla, Stefania; Pes, Valentina; Perria, Chiara; Cuccuru, Gianmauro; Atzeni, Rossano; Serra, Gigliola; Cucca, Francesco; Sotgiu, Stefano; Hennekam Raoul, C; Crisponi, Laura | |
| Dissection of the BAFF pathway in Multiple Sclerosis with a view toward more specific and effective therapies | 1-gen-2019 | Olla, S; Idda, Ml; Deiana, M; Delogu, G; Lodde, V; Steri, M; Orrù, V; Floris, M; Pitzalis, M Pala M; Sidore, C; Mulas, A; Piras, Mg; Lobina, M; Lai, S; Marongiu, Mara; Serra, V; Marongiu, Michele; Sole, G; Busonero, F; Maschio, A; Dei, M; Deidda, F; Poddie, F; Farina, G; Frau, J; Costa, G; Coghe, G; Lorefice, L; Fenu, G; Marrosu, Mg; Cocco, E; Fiorillo, E; Zoledziewska, M; Cucca, F | |
| Rational design and synthesis of edaravone- remyelinating analogues and probes: a preliminary SAR | 1-gen-2019 | Seneci, Pierfausto; Colombo, Eleonora; Pericolo, Mattia; Veroni, Caterina; Formato, Alessia; Mele, Giada; Camerini, Serena; Crescenzi, Marco; Stefania Brignone, Maria; Mallozzi, Cinzia; Olla, Stefania; Agresti, Cristina | |
| Genetic-Driven Druggable Target Identification and Validation | 1-gen-2018 | Floris, Matteo; Olla, Stefania; Schlessinger, David; Cucca, Francesco | |
| Molecular Similarity in Computational Toxicology | 1-gen-2018 | Floris, Matteo; Olla, Stefania | |
| A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials | 1-gen-2017 | Eleuteri C.; Olla S.; Veroni C.; Umeton R.; Mechelli R.; Romano S.; Buscarinu M.C.; Ferrari F.; Calo G.; Ristori G.; Salvetti M.; Agresti C. |